X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2620) 2620
Publication (356) 356
Newsletter (98) 98
Book Review (68) 68
Magazine Article (13) 13
Book Chapter (12) 12
Conference Proceeding (6) 6
Book / eBook (1) 1
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bupropion (1616) 1616
humans (1536) 1536
pharmacology & pharmacy (1277) 1277
male (1064) 1064
index medicus (990) 990
female (756) 756
adult (647) 647
psychiatry (633) 633
animals (583) 583
bupropion - therapeutic use (523) 523
middle aged (473) 473
smoking cessation (454) 454
sustained-release bupropion (449) 449
bupropion - pharmacology (441) 441
neurosciences (429) 429
smoking cessation - methods (365) 365
nicotine (336) 336
rats (328) 328
varenicline (328) 328
antidepressants (301) 301
treatment outcome (301) 301
smoking (284) 284
smoking-cessation (265) 265
dose-response relationship, drug (261) 261
depression (259) 259
article (250) 250
bupropion - adverse effects (248) 248
double-blind (243) 243
bupropion - administration & dosage (241) 241
smoking cessation programs (228) 228
dopamine (225) 225
drug therapy (224) 224
receptor partial agonist (224) 224
research (224) 224
double-blind method (218) 218
antidepressive agents, second-generation - therapeutic use (206) 206
pharmacology (206) 206
clinical neurology (193) 193
pharmacotherapy (193) 193
pharmacology/toxicology (188) 188
placebo (184) 184
adolescent (183) 183
drug interactions (183) 183
randomized controlled-trial (171) 171
antidepressive agents - pharmacology (169) 169
analysis (168) 168
aged (167) 167
mice (167) 167
medicine & public health (166) 166
drugs (162) 162
efficacy (160) 160
tobacco use disorder - drug therapy (160) 160
antidepressive agents - therapeutic use (154) 154
dopamine uptake inhibitors - pharmacology (153) 153
risk factors (151) 151
health aspects (148) 148
young adult (144) 144
dependence (142) 142
dopamine uptake inhibitors - therapeutic use (142) 142
substance abuse (141) 141
care and treatment (137) 137
pharmacokinetics (137) 137
dosage and administration (134) 134
nicotine replacement therapy (134) 134
tobacco (132) 132
antidepressant (127) 127
fluoxetine (127) 127
placebo-controlled trial (125) 125
cigarette-smoking (124) 124
nicotine - administration & dosage (124) 124
depressive disorder - drug therapy (123) 123
nicotinic agonists - therapeutic use (123) 123
time factors (123) 123
antidepressive agents, second-generation - pharmacology (122) 122
drug therapy, combination (121) 121
antidepressive agents, second-generation - adverse effects (120) 120
cessation (120) 120
rats, sprague-dawley (119) 119
smokers (117) 117
delayed-action preparations (114) 114
metabolites (114) 114
benzazepines - therapeutic use (112) 112
bupropion - pharmacokinetics (112) 112
clinical trials (112) 112
depressive disorder, major - drug therapy (111) 111
mental disorders (111) 111
major depressive disorder (110) 110
nicotine - pharmacology (110) 110
toxicology (109) 109
complications and side effects (104) 104
major depression (103) 103
quinoxalines - therapeutic use (103) 103
metabolism (102) 102
depression, mental (101) 101
in-vitro (101) 101
smoking - drug therapy (99) 99
psychopharmacology (97) 97
naltrexone (96) 96
biomedicine (95) 95
nicotine - therapeutic use (95) 95
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2690) 2690
German (12) 12
Turkish (10) 10
Japanese (7) 7
French (5) 5
Hungarian (3) 3
Polish (2) 2
Russian (2) 2
Dutch (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annual Review of Pharmacology and Toxicology, ISSN 0362-1642, 2009, Volume 49, Issue 1, pp. 57 - 71
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2006, Volume 46, Issue 12, pp. 1426 - 1438
Cytochrome P450 2B6 (CYP2B6) is involved in the metabolism of drugs such as bupropion, efavirenz, propofol, and selegiline, among others. More than 200... 
HPLC/MS/MS | P450 2B6 | rhCYP2B6 | Drug‐drug interactions | in vitro | Drug-drug interactions | In vitro | Raloxifene Hydrochloride - pharmacology | Cytochrome P-450 Enzyme Inhibitors | Humans | Microsomes, Liver - metabolism | Sertraline - chemistry | Bupropion - analogs & derivatives | Cytochrome P-450 Enzyme System - metabolism | Antifungal Agents - chemistry | Xenobiotics - pharmacology | Reverse Transcriptase Inhibitors - chemistry | Xenobiotics - classification | Clotrimazole - metabolism | Platelet Aggregation Inhibitors - pharmacology | Oxazines - pharmacology | Antifungal Agents - pharmacology | Itraconazole - metabolism | Serotonin Uptake Inhibitors - metabolism | Clotrimazole - pharmacology | Serotonin Uptake Inhibitors - chemistry | Antidepressive Agents, Second-Generation - pharmacology | Clotrimazole - chemistry | Itraconazole - chemistry | Selective Estrogen Receptor Modulators - metabolism | Ticlopidine - analogs & derivatives | Raloxifene Hydrochloride - metabolism | Platelet Aggregation Inhibitors - chemistry | Oxazines - chemistry | Kinetics | Serotonin Uptake Inhibitors - pharmacology | Selective Estrogen Receptor Modulators - pharmacology | Bupropion - metabolism | Ticlopidine - pharmacology | Area Under Curve | Reverse Transcriptase Inhibitors - pharmacology | Ticlopidine - chemistry | Benzoxazines | Xenobiotics - pharmacokinetics | Itraconazole - pharmacology | Oxazines - metabolism | Microsomes, Liver - drug effects | Antifungal Agents - metabolism | Ticlopidine - metabolism | Molecular Structure | Platelet Aggregation Inhibitors - metabolism | Sertraline - metabolism | Sertraline - pharmacology | Selective Estrogen Receptor Modulators - chemistry | Algorithms | Bupropion - pharmacology | Reverse Transcriptase Inhibitors - metabolism | Antidepressive Agents, Second-Generation - metabolism | Raloxifene Hydrochloride - chemistry | Cytochrome P-450 CYP2B6 | Cytochromes | Research | Health aspects | Drug interactions
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2017, Volume 234, Issue 23, pp. 3507 - 3520
Racemic (RS)-amisulpride (Solian®) is an atypical antipsychotic drug used to treat schizophrenia and dysthymia. Blockade of dopamine D2/D3 and/or serotonin... 
Drug discrimination | Neurosciences | Amisulpride | Schizophrenia | Isomers | Anxiolytics | Discriminative stimulus | Antipsychotics | Biomedicine | Antidepressants | C57BL/6 mice | Benzamides | Pharmacology/Toxicology | Psychiatry | CORTICAL MEMBRANES | PSYCHIATRY | HIGH-AFFINITY | MAJOR DEPRESSION | D-2 RECEPTORS | NEUROSCIENCES | RECEPTOR ANTAGONIST | LIMBIC SELECTIVITY | 5-HT7 RECEPTOR | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | RAT-BRAIN | DOPAMINE-RECEPTORS | Sulpiride - pharmacology | Conditioning, Operant - physiology | Male | Sulpiride - analogs & derivatives | Clozapine - pharmacology | Discrimination Learning - drug effects | Clozapine - chemistry | Conditioning, Operant - drug effects | Antidepressive Agents - chemistry | Anti-Anxiety Agents - chemistry | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Quetiapine Fumarate - pharmacology | Benzamides - chemistry | Quetiapine Fumarate - chemistry | Mice, Inbred C57BL | Chlorpromazine - chemistry | Risperidone - pharmacology | Anti-Anxiety Agents - pharmacology | Chlorpromazine - pharmacology | Risperidone - chemistry | Discrimination Learning - physiology | Animals | Antipsychotic Agents - chemistry | Mice | Antipsychotic Agents - pharmacology | Sulpiride - chemistry | Dosage and administration | Antipsychotic drugs | Comparative analysis | Drug interactions | Antianxiety agents | Stereoisomers | Drugs | Neuroleptics | Olanzapine | Operant conditioning | Mental disorders | Aripiprazole | Benzamide | Metoclopramide | Chlorpromazine | Sulpiride | Serotonin S7 receptors | Psychotropic drugs | Imipramine | Receptors | Bupropion | Mianserin | Risperidone | Dopamine D2 receptors | Drug dosages | Quetiapine | Raclopride | Dopamine | Serotonin | Dopamine D3 receptors | Chlordiazepoxide | Pharmacology | Clozapine | Derivatives | Properties (attributes) | Serotonin receptors
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 06/2013, Volume 107, pp. 42 - 47
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 2/2013, Volume 27, Issue 2, pp. 213 - 221
Previous studies have shown that drugs which block the reuptake of catecholamine neurotransmitters improve impulse control in diseases such as attention... 
monoamine reuptake | ADHD | serotonin | rat | impulsivity | attention | dopamine | Noradrenaline | 5-choice serial reaction time task | NORADRENALINE REUPTAKE INHIBITOR | PSYCHIATRY | NEUROSCIENCES | PREFRONTAL CORTEX | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | BORDERLINE PERSONALITY-DISORDER | RAT FRONTAL-CORTEX | NOREPINEPHRINE TRANSPORTER | IN-VIVO | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | EXTRACELLULAR CONCENTRATIONS | FUNCTIONAL NEUROCHEMISTRY | Fluoxetine - pharmacology | Norepinephrine - pharmacology | Choice Behavior - drug effects | Rats | Acetamides - pharmacology | Male | Impulsive Behavior - physiopathology | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Idazoxan - pharmacology | Venlafaxine Hydrochloride | Animals | Cyclobutanes - pharmacology | Reaction Time - drug effects | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Bupropion - pharmacology | Hypnotics and Sedatives - pharmacology | Cyclohexanols - pharmacology | Paroxetine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Serotonin uptake inhibitors | Neurotransmitters | Dosage and administration | Research | Monoamines | Impulse | Drugs | Dopamine | Fluoxetine | Attention deficit hyperactivity disorder | impulsive behavior | Catecholamines | Data processing | Suicide | Reaction time task | sibutramine | paroxetine | Antidepressants | Venlafaxine | Norepinephrine | bupropion | monoamines
Journal Article